tiprankstipranks
Trending News
More News >
GlaxoSmithKline (GSK)
NYSE:GSK
US Market
Advertisement

GlaxoSmithKline (GSK) Technical Analysis

Compare
5,146 Followers

Technical Sentiment

Overall Consensus
Strong Buy
16Bullish
6Neutral
0Bearish
Technical Analysis Consensus
Buy
4Bullish
6Neutral
0Bearish
Moving Average Consensus
Strong Buy
12Bullish
0Neutral
0Bearish
GlaxoSmithKline’s (GSK) Moving Averages Convergence Divergence (MACD) indicator is 0.88, suggesting GlaxoSmithKline is a Buy.
GlaxoSmithKline’s (GSK) 20-Day exponential moving average is 46.73, while GlaxoSmithKline’s (GSK) share price is $47.86, making it a Buy.
GlaxoSmithKline’s (GSK) 50-Day exponential moving average is 44.80, while GlaxoSmithKline’s (GSK) share price is $47.86, making it a Buy.

GlaxoSmithKline (GSK) Pivot Points

Dec 01, 2025, 09:28 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
47.51
47.74
47.88
48.12
48.26
48.49
48.63
Fibonacci
47.74
47.89
47.98
48.12
48.26
48.35
48.49
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

GlaxoSmithKline (GSK) Moving Averages

Dec 01, 2025, 09:28 AM
Period
Simple
Exponential
MA5
47.52Buy
47.57Buy
MA10
47.21Buy
47.31Buy
MA20
47.03Buy
46.73Buy
MA50
44.52Buy
44.80Buy
MA100
41.42Buy
42.54Buy
MA200
39.35Buy
39.76Buy
GlaxoSmithKline’s (GSK) 10-Day exponential moving average is 47.31, while GlaxoSmithKline’s (GSK) share price is $47.86, making it a Buy.
GlaxoSmithKline’s (GSK) 100-Day exponential moving average is 42.54, while GlaxoSmithKline’s (GSK) share price is $47.86, making it a Buy.
GlaxoSmithKline’s (GSK) stock price is $47.86 and GlaxoSmithKline’s (GSK) 50-day simple moving average is 44.52, creating a Buy signal.
GlaxoSmithKline’s (GSK) stock price is $47.86 and GlaxoSmithKline’s (GSK) 100-day simple moving average is 41.42, creating a Buy signal.
GlaxoSmithKline’s (GSK) stock price is $47.86 and GlaxoSmithKline’s (GSK) 200-day simple moving average is 39.35, creating a Buy signal.

GlaxoSmithKline (GSK) Technical Indicators

Dec 01, 2025, 09:28 AM
Name
Value
Implied Action
RSI (14)
61.99
Neutral
STOCH (9,6)
76.01
Neutral
STOCHRSI (14)
69.62
Neutral
MACD (12,26)
0.88
Buy
ADX (14)
26.87
Neutral
Williams %R
-28.65
Buy
CCI (14)
71.64
Neutral
ATR (14)
0.95
-
Ultimate Oscillator
48.17
Neutral
ROC
3.53
Buy
GlaxoSmithKline’s (GSK) Relative Strength Index (RSI) is 61.99, creating a Neutral signal.
GlaxoSmithKline’s (GSK) Trend Strength Indicator (ADX) is 26.87, creating a Neutral signal.
GlaxoSmithKline’s (GSK) Commodity Channel Index (CCI) is 71.64, creating a Neutral signal.
GlaxoSmithKline’s (GSK) Price Rate of Change (ROC) is 3.53, creating a Buy signal.

FAQ

Is GSK a Buy, Hold, or Sell?
Based on GSK’s technical indicators, GSK is a Strong Buy.
    What is GSK’s RSI (14)?
    GSK’s RSI (14) is 61.99, which suggests GSK is a Neutral.
      What is GSK’s MACD?
      GSK’s MACD is 0.88, which suggests GSK is a Buy.
        What is GSK’s 5-day moving average?
        GSK’s 5-day moving average is 47.52, which suggests GSK is a Buy.
          What is GSK’s 20-day moving average?
          GSK 20-day moving average is 47.03, which suggests GSK is a Buy.
            What is GSK’s 50-day moving average?
            GSK’s 50-day moving average is 44.52, which suggests GSK is a Buy.
              What is GSK’s 200-day moving average?
              GSK’s 200-day moving average is 39.35, which suggests GSK is a Buy.
                What is GSK’s Williams % R (14)?
                GSK’s Williams % R (14) is -28.65, which suggests GSK is a Buy.
                  What is GSK’s CCI (14)?
                  GSK’s CCI (14) is 71.64, which suggests GSK is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis